News

Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product

CHICAGO, IL / ACCESSWIRE / December 1, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

2 years ago

iZafe Group Board Member Bosse Johansson Purchases 800,000 Shares

STOCKHOLM, SWEDEN / ACCESSWIRE / December 01, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group's board member, Bosse Johansson, acquired 800,000…

2 years ago

Avoro Ventures Adds Mark Chin as a Partner

NEW YORK--(BUSINESS WIRE)--Avoro Ventures, a global venture capital firm investing in life sciences, announced today that Mark Chin has joined…

2 years ago

Avoro Ventures Adds Mark Chin as a Partner

NEW YORK--(BUSINESS WIRE)--Avoro Ventures, a global venture capital firm investing in life sciences, announced today that Mark Chin has joined…

2 years ago

DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy

QIAGEN’s ForenSeq Kintelligence System recently used by DNA Labs International in the U.S. to solve unidentified remains case in Oregon…

2 years ago

Curated Mental Health Elevates Professional Development With Exclusive Presentation on Transcranial Magnetic Stimulation (TMS)

NEW YORK, NY / ACCESSWIRE / December 1, 2023 / By the end of the decade, projections suggest that market…

2 years ago

Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray – MMA Champ Cat Zingano Now Official VST Ambassador

Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of…

2 years ago

NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.

The option agreement grants NLS Pharmaceutics Ltd. the exclusive option to in-license all of Aexon Labs' assets for the potential…

2 years ago

Regeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio

TARRYTOWN, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a conference call and simultaneous…

2 years ago

Reviva Pharmaceuticals to Participate in The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

CUPERTINO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage…

2 years ago